Medication

March 20, 2019 - 12:25 pm
COLUMBIA, S.C. (AP) — Some South Carolina faith leaders are showing their support for legislation to legalize the medicinal use of marijuana for individuals with terminal, debilitating medical conditions. A diverse group of clergy held a news conference Wednesday at the Statehouse in support of the...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where all of their money comes from. (AP Photo/Elise Amendola)
March 18, 2019 - 8:00 am
WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad echoes objections from drugmakers by warning that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors. The one-minute spot is the handiwork of...
Read More
In this Thursday, March 7, 2019 photo, New Mexico state Rep. Javier Martinez of Albuquerque, right, rallies support for a bill to authorize recreational marijuana consumption and sales through state-owned stores in Santa Fe, N.M. New Mexico took a step toward legalizing recreational marijuana when its House approved a bill that would allow state-run stores and require customers to carry a receipt with their cannabis or face penalties. The measure, narrowly approved Thursday, March 7, 2019, following a late-night floor debate, mixes major provisions of a Republican-backed Senate bill that emphasizes aggressive regulation with a draft by Democrats concerned about the U.S. war on drugs. (AP Photo/Morgan Lee)
March 12, 2019 - 1:34 am
SANTA FE, N.M. (AP) — New Mexico would become the first U.S. state to set up its own government-operated marijuana stores and subsidize medical cannabis for the poor under a bill brokered between Republicans and Democrats, as a new wave of states weighs legislation that would legalize recreational...
Read More
Acting OMB Director Russ Vought speaks during a press briefing at the White House, Monday, March 11, 2019, in Washington. (AP Photo/ Evan Vucci)
March 11, 2019 - 9:41 pm
WASHINGTON (AP) — The Latest on President Donald Trump's proposed 2020 budget (all times local): 9:35 p.m. Hospital groups are objecting strongly to hundreds of billions of dollars in proposed Medicare and Medicaid payment cuts in President Donald Trump's budget. Two major hospital trade groups did...
Read More
FILE - In this March 1, 2019 file photo Sen. Kamala Harris, D-Calif., speaks at the Black Enterprise Women of Power Summit, in Las Vegas. A growing list of Democratic presidential contenders want the U.S. government to legalize marijuana, reflecting a nationwide shift. Harris says it's the "smart thing to do." (AP Photo/John Locher, File)
March 09, 2019 - 6:54 pm
LOS ANGELES (AP) — A growing list of Democratic presidential contenders want the U.S. government to legalize marijuana, reflecting a nationwide shift as more Americans look favorably on cannabis. Making marijuana legal at the federal level is the "smart thing to do," says California Sen. Kamala...
Read More
FILE - This Oct. 14, 2015 file photo shows the Food & Drug Administration campus in Silver Spring, Md. On Friday, March 8, 2019, the FDA approved Roche’s Tecentriq, the first cancer immunotherapy for treating an aggressive type of breast cancer. (AP Photo/Andrew Harnik, File)
March 08, 2019 - 6:26 pm
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer. Swiss drugmaker Roche's Tecentriq was OK'd Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It's to be given with chemotherapy, the standard...
Read More
This photo provided by Janssen Global Services shows Spravato nasal spray. Spravato, a mind-altering medication related to the club drug Special K, won U.S. approval Tuesday, March 5, 2019, for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. (Janssen Global Services via AP)
March 06, 2019 - 12:11 am
WASHINGTON (AP) — A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. The nasal spray from Johnson & Johnson...
Read More
FILE - This Feb. 17, 2016 file photo shows marijuana plants at a home in Honolulu. Hawaii is among the bluest of states, but when it comes to legalizing marijuana, it is out of step with liberal stalwarts such as California and Vermont. A bill that would legalize marijuana in the islands faces significant obstacles from leaders worried about contradicting federal law and jeopardizing Hawaii’s existing medical marijuana program. It faces a Friday, March 1, 2019, deadline to pass committee. (AP Photo/Marina Riker, File)
March 01, 2019 - 4:29 pm
HONOLULU (AP) — On the political spectrum, Hawaii is among the bluest of states. Democrats control all the levers of power at the state and federal levels, and voters back Democratic presidential candidates over Republicans by some of the widest margins in the U.S. The state has committed to the...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:42 pm
WASHINGTON (AP) — Drawing from their personal experiences, senators on Tuesday chastised drug company executives over the high cost of prescription drugs, as the company officials cautioned that heavy-handed congressional action could jeopardize medical breakthroughs going forward. Tuesday's Senate...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:41 pm
WASHINGTON (AP) — The Latest on top pharmaceutical executives testifying before Senate lawmakers on rising drug prices (all times local): 1:30 Senators are urging top pharmaceutical executives to help Congress take action against the industry's worst actors who hike prices on once-cheap drugs...
Read More

Pages